About the Vaccine Preventable Diseases Session
Vaccine-preventable diseases are infectious illnesses that can be avoided through timely and routine vaccination. Vaccines work by training the immune system to recognize and combat specific pathogens, such as viruses or bacteria, before an individual is exposed to the actual disease. Common vaccine-preventable diseases include measles, mumps, rubella, polio, hepatitis, and influenza. Vaccination not only provides individual protection but also contributes to community immunity, reducing the overall spread of these diseases within populations. Immunization is a crucial aspect of public health, preventing the occurrence and transmission of communicable diseases. By following recommended vaccination schedules and participating in vaccination campaigns, individuals can significantly reduce their risk of contracting and spreading these preventable illnesses. Public health efforts focus on raising awareness about the importance of vaccination, dispelling myths and misconceptions, and ensuring access to vaccines. These initiatives are integral in maintaining the health and well-being of individuals and communities, preventing outbreaks of vaccine-preventable diseases, and advancing global efforts to eradicate or control these communicable illnesses.
Topics Covered in Vaccine Preventable Diseases
Measles, mumps and rubella control
Polio eradication and surveillance
Hepatitis and influenza prevention
Herd immunity and outbreak containment
Routine childhood immunization schedules
Vaccine myths and public misconceptions
Featured Speakers — Vaccine Preventable Diseases 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Vaccine Preventable Diseases Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IPHC 2027
Why Attend the Vaccine Preventable Diseases Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Vaccine Preventable Diseases work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Vaccine Preventable Diseases research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the Vaccine Preventable Diseases track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Vaccine Preventable Diseases Conference 2027 — FAQs
What is the Vaccine Preventable Diseases track at IPHC 2027?
The Vaccine Preventable Diseases track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Vaccine Preventable Diseases. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Vaccine Preventable Diseases sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Vaccine Preventable Diseases are all welcome — whether presenting or attending.
Can I present my research in the Vaccine Preventable Diseases track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Vaccine Preventable Diseases sessions?
Yes. IPHC 2027 is a hybrid conference — attend the Vaccine Preventable Diseases track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
